Influence of additional atherogenic risk factors on silent ischemia detected by sestamibi myocardial perfusion imaging in essential hypertensive patients

被引：0
|
作者：
Dumont, M. [1 ]
Lefebvre, J. [1 ]
Cote, C. [1 ]
Lacourciere, Y. [1 ]
机构：
[1] CHU Quebec, Quebec City, PQ, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 50 条
  • [1] Screening for silent coronary artery disease as detected by Tc-99m Sestamibi spect myocardial perfusion imaging in asymptomatic essential hypertensive patients - The influence of additional atherogenic risk factors
    Lacourciere, Y.
    Lefebvre, J.
    Poirier, L.
    Dumont, M.
    Cote, C.
    JOURNAL OF HYPERTENSION, 2006, 24 : 277 - 277
  • [2] Prevalence of silent coronary artery disease in hypertensive patients with peripheral arterial disease detected by dipyridamole Sestamibi myocardial perfusion imaging
    Dumont, M.
    Cote, C.
    Lacourciere, Y.
    Labbe, R.
    Lefebvre, J.
    Poirier, L.
    Milot, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 492 - 492
  • [3] Frequency and severity of silent ischemia as detected by stress dipyridamole Tc-99m sestamibi SPECT imaging in patients with hypertension and other atherogenic risk factors
    Lacourciere, Y.
    Lefebvre, J.
    Poirier, L.
    Cote, C.
    Dumont, M.
    JOURNAL OF HYPERTENSION, 2007, 25 (12) : A13 - A13
  • [4] Clinical predictors of silent coronary artery disease detected by sestamibi myocardial imaging in hypertensive and diabetic patients
    LeCourciere, Yves
    Dumont, Marcel
    Lefebvre, Jean
    Poirier, Luc
    Cote, Christian
    DIABETES, 2006, 55 : A73 - A73
  • [5] Frequency and severity of silent ischemia, as detected by stress dipyridamole TC-99M sestamibi spect imaging in patients with hypertension and atherogenic risk factor
    Lacourciere, Y.
    Lefebvre, J.
    Poirier, L.
    Cote, C.
    Dumont, M.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2007, 100 (08): : 677 - 678
  • [6] Detection with dipyridamole Sestamibi myocardial perfusion imaging of hypertensive patients with peripheral arterial disease who are at greater risk for silent coronary artery disease
    Dumont, M.
    Cote, C.
    Milot, A.
    Labbe, R.
    Lefebvre, J.
    Lacourciere, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S272 - S272
  • [7] Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension
    Domenico Rendina
    Renato Ippolito
    Gianpaolo De Filippo
    Riccardo Muscariello
    Daniela De Palma
    Silvana De Bonis
    Michele Schiano di Cola
    Domenico Benvenuto
    Maurizio Galderisi
    Pasquale Strazzullo
    Ferruccio Galletti
    Internal and Emergency Medicine, 2017, 12 : 171 - 179
  • [8] Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension
    Rendina, Domenico
    Ippolito, Renato
    De Filippo, Gianpaolo
    Muscariello, Riccardo
    De Palma, Daniela
    De Bonis, Silvana
    di Cola, Michele Schiano
    Benvenuto, Domenico
    Galderisi, Maurizio
    Strazzullo, Pasquale
    Galletti, Ferruccio
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (02) : 171 - 179
  • [9] MYOCARDIAL PERFUSION RESERVE AND MYOCARDIAL HYPERTROPHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND SILENT ISCHEMIA
    DUBOV, PB
    FOFANOVA, TV
    OSTROUMOV, EN
    YURENEV, AP
    KARDIOLOGIYA, 1994, 34 (5-6) : 126 - 128
  • [10] Prevalence of myocardial ischemia in patients with metabolic syndrome detected by myocardial perfusion imaging
    Peovska, I.
    Maksimovic, J.
    Vavlukis, M.
    Kostova, N.
    Gorceva, D. Pop
    Majstorov, V.
    Zdraveska, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A35 - A35
12345